Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has announced a new application for the quotation of 4,615,385 ordinary fully paid securities under the ASX code CHM, set to be issued on April 30, 2024. This application follows previous market announcements and adheres to the ASX Listing Rules, signaling a potential new investment opportunity for market participants.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
